INNO Share Price Performance
CA$12.00
-1.97 (-14.13%)
Price CA$12.00
Share Pricen/a
InnoCan Pharma Corporation (CSE:INNO) Stocks Pounded By 25% But Not Lagging Industry On Growth Or Pricing
Nov 26
InnoCan Pharma Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
INNO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
InnoCan Pharma Corporation Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.72
- 88.47%
- -11.96%
- 23.0%
About INNO
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for epilepsy and pain management. The company is involved in the development and sale of CBD-integrated pharmaceuticals and topical products. In addition, it develops and markets a portfolio of self-care products for healthier lifestyle. The company was incorporated in 2018 and is headquartered in Calgary, Canada.
